Production (Stage)
Organogenesis Holdings Inc.
ORGO
$3.03
$0.155.21%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -15.88M | 861.00K | -7.38M | -16.55M | 5.81M |
| Total Depreciation and Amortization | 17.34M | 17.03M | 16.79M | 16.16M | 15.42M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 51.88M | 45.21M | 49.24M | 50.20M | 31.55M |
| Change in Net Operating Assets | -48.90M | -48.89M | -44.76M | -27.89M | -26.95M |
| Cash from Operations | 4.44M | 14.21M | 13.89M | 21.92M | 25.83M |
| Capital Expenditure | -11.44M | -10.03M | -10.00M | -13.41M | -19.02M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -11.44M | -10.03M | -10.00M | -13.41M | -19.02M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -66.26M | -67.64M | -6.80M | -6.56M | -5.90M |
| Issuance of Common Stock | 1.09M | 1.25M | 186.00K | 181.00K | 181.00K |
| Repurchase of Common Stock | -27.33M | -26.66M | -1.17M | -1.18M | -1.16M |
| Issuance of Preferred Stock | 120.69M | 120.69M | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 28.19M | 27.64M | -7.79M | -7.55M | -6.88M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 21.19M | 31.81M | -3.90M | 969.00K | -69.00K |